|
JPH0747045B2
(ja)
|
1986-10-15 |
1995-05-24 |
株式会社大協精工 |
積層した注射器用滑栓
|
|
JP3100727B2
(ja)
|
1992-01-23 |
2000-10-23 |
株式会社大協精工 |
変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品
|
|
JP3172057B2
(ja)
|
1995-04-05 |
2001-06-04 |
株式会社大協精工 |
ラミネートゴム栓
|
|
US20020035058A1
(en)
|
1996-05-15 |
2002-03-21 |
The University Of Sheffield |
Isopentenyl pyrophosphate isomerase (IPI) and/or prenyl transferase inhibitors
|
|
US6030831A
(en)
|
1997-09-19 |
2000-02-29 |
Genetech, Inc. |
Tie ligand homologues
|
|
US6172071B1
(en)
|
1998-07-30 |
2001-01-09 |
Hughes Institute |
Lipid-lowering quinazoline derivative
|
|
JP3512349B2
(ja)
|
1999-01-29 |
2004-03-29 |
株式会社大協精工 |
柱状ゴム要素の成形型
|
|
JP2002536459A
(ja)
|
1999-02-12 |
2002-10-29 |
プレジデント アンド フェローズ オブ ハーヴァード カレッジ |
アテローム性動脈硬化症性病変の形成の阻害
|
|
US6629949B1
(en)
|
2000-05-08 |
2003-10-07 |
Sterling Medivations, Inc. |
Micro infusion drug delivery device
|
|
US6659982B2
(en)
|
2000-05-08 |
2003-12-09 |
Sterling Medivations, Inc. |
Micro infusion drug delivery device
|
|
JP2002209975A
(ja)
|
2001-01-19 |
2002-07-30 |
Daikyo Seiko Ltd |
医薬バイアル用ラミネートゴム栓
|
|
NZ527408A
(en)
|
2001-02-22 |
2005-04-29 |
Skyepharma Canada Inc |
Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
|
|
KR20100029861A
(ko)
|
2001-11-16 |
2010-03-17 |
제넨테크, 인크. |
안지오포이에틴-유사 단백질 3 angptl3을 함유하는 조성물 및 이를 사용하는 방법
|
|
AU2003298607B9
(en)
|
2002-10-29 |
2011-08-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
JP2005080508A
(ja)
|
2003-09-04 |
2005-03-31 |
Sankyo Co Ltd |
脂質代謝改善剤の試験方法
|
|
AU2006223579A1
(en)
|
2005-03-11 |
2006-09-21 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
ZA200904022B
(en)
|
2006-12-08 |
2010-08-25 |
Lexicon Pharmaceuticals Inc |
Monoclonal antibodies against ANGPTL3
|
|
AR070315A1
(es)
*
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
US20130064834A1
(en)
|
2008-12-15 |
2013-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to pcsk9
|
|
EP2216016A1
(en)
|
2009-02-06 |
2010-08-11 |
LEK Pharmaceuticals d.d. |
Process for the preparation of a pharmaceutical composition comprising ezetimibe
|
|
CA2788777C
(en)
|
2009-02-23 |
2015-02-17 |
NanoRx, Inc. |
Policosanol nanoparticles
|
|
CN101852805B
(zh)
|
2009-03-31 |
2015-04-01 |
浙江大学 |
Angptl3作为卵巢癌的诊断标记物的用途
|
|
PE20160507A1
(es)
|
2009-07-14 |
2016-05-20 |
Scripps Research Inst |
Diferenciacion de celulas madre mesenquimales
|
|
WO2011085271A2
(en)
|
2010-01-08 |
2011-07-14 |
Isis Pharmaceuticals, Inc. |
Modulation of angiopoietin-like 3 expression
|
|
AR087329A1
(es)
|
2011-06-17 |
2014-03-19 |
Regeneron Pharma |
Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana
|
|
CA2839573A1
(en)
|
2011-06-21 |
2012-12-27 |
Alnylam Pharmaceuticals, Inc. |
Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof
|
|
JP6176849B2
(ja)
|
2011-07-19 |
2017-08-09 |
中外製薬株式会社 |
アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
|
|
US20150239970A1
(en)
|
2012-10-25 |
2015-08-27 |
Medimmune, Llc |
Stable, Low Viscosity Antibody Formulation
|
|
ES2753381T3
(es)
|
2013-03-14 |
2020-04-08 |
Uab Research Foundation |
Miméticos de apolipoproteína y usos de los mismos
|
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
|
TW201534324A
(zh)
|
2013-06-07 |
2015-09-16 |
Sanofi Sa |
藉由投與pcsk9抑制劑抑制動脈粥狀硬化的方法
|
|
HK1224186A1
(zh)
|
2013-11-20 |
2017-08-18 |
Cymabay Therapeutics, Inc. |
纯阖家族型高胆固醇血症的治疗
|
|
PL3087183T3
(pl)
|
2013-12-24 |
2021-01-11 |
Ionis Pharmaceuticals, Inc. |
Modulacja ekspresji białka angiopoetynopodobnego 3
|
|
WO2015168589A2
(en)
|
2014-05-01 |
2015-11-05 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulating angiopoietin-like 3 expression
|
|
KR20230074283A
(ko)
|
2014-07-16 |
2023-05-26 |
사노피 바이오테크놀로지 |
이형접합성 가족성 고콜레스테롤혈증(heFH) 환자의 치료방법
|
|
AU2015289617B2
(en)
|
2014-07-16 |
2021-04-15 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating high cardiovascular risk patients with hypercholesterolemia
|
|
CA2954082A1
(en)
|
2014-10-03 |
2016-04-07 |
Ngm Biopharmaceuticals, Inc. |
Methods and compositions for treatment of conditions associated with elevated triglycerides
|
|
TW201713690A
(zh)
|
2015-08-07 |
2017-04-16 |
再生元醫藥公司 |
抗angptl8抗體及其用途
|
|
IL260931B2
(en)
|
2016-02-17 |
2024-09-01 |
Regeneron Pharma |
Methods of treating or preventing atherosclerosis by blocking ANGPTL3
|
|
MA43734A
(fr)
|
2016-03-03 |
2018-11-28 |
Regeneron Pharma |
Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3
|
|
PL3439689T3
(pl)
|
2016-04-08 |
2022-01-31 |
Regeneron Pharmaceuticals, Inc. |
Sposoby leczenia hiperlipidemii inhibitorem angptl8 i inhibitorem angptl3
|
|
MD3448426T2
(ro)
|
2016-04-28 |
2025-09-30 |
Regeneron Pharma |
Metode de tratament al pacienților cu hipercolesterolemie familială
|
|
US11603407B2
(en)
|
2017-04-06 |
2023-03-14 |
Regeneron Pharmaceuticals, Inc. |
Stable antibody formulation
|
|
MX2023001481A
(es)
|
2020-08-07 |
2023-03-08 |
Regeneron Pharma |
Metodos para tratar pacientes con hipercolesterolemia refractaria.
|